Leucovorin

Discover Leucovorin (Sodium Folinate), a vital medication used for methotrexate rescue, chemotherapy adjunct, and folate deficiency. Learn about its uses,

Leucovorin Leucovorin calcium Methotrexate rescue Folinic acid uses Colorectal cancer treatment Chemotherapy adjunct Folate deficiency treatment Leucovorin side effects
🏷 ATC Code: V03AF03 📂 Detoxifying agents for antineoplastic treatment 🕐 Updated: Mar 14, 2026 ✓ Medical Reference

Looking to order Leucovorin?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Leucovorin?

Leucovorin, also known as folinic acid or sodium folinate, is a synthetic form of a B vitamin, specifically a reduced folate. It is not an active drug itself but is readily converted in the body into active forms of folate, which are essential for various metabolic processes, including DNA synthesis, repair, and red blood cell production. Unlike folic acid, which needs to be converted into its active forms by the enzyme dihydrofolate reductase (DHFR), Leucovorin bypasses this step, making it immediately available for the body's needs. This unique characteristic is crucial for its therapeutic applications, particularly in oncology and in managing certain types of toxicity.

It's important to understand that Leucovorin is distinct from folic acid, even though both are forms of folate. Folic acid is a precursor that requires enzymatic conversion, while Leucovorin is already in a reduced, more active state. This difference is key to its role as a 'rescue' therapy and as an adjunct in specific chemotherapy regimens. Leucovorin is available in various forms, including oral tablets and injectable solutions (intravenous or intramuscular), allowing for flexible administration based on the patient's condition and the specific therapeutic goal.

How Does it Work?

The mechanism of action for Leucovorin is directly related to its role as a reduced folate. In the body, Leucovorin is converted into tetrahydrofolate, the active form of folate. This active folate then participates in crucial biochemical reactions, primarily as a coenzyme in the synthesis of purines and pyrimidines, which are fundamental building blocks of DNA and RNA. It also plays a vital role in amino acid metabolism.

Its therapeutic efficacy stems from two main pathways:

  • Reversing Antifolate Effects: Certain drugs, like methotrexate, work by inhibiting DHFR, an enzyme necessary for converting dietary folate into its active forms. By bypassing this enzymatic step, Leucovorin provides the body with pre-formed active folate, thus 'rescuing' cells from the toxic effects of methotrexate and other antifolate drugs. This allows normal cells to continue DNA synthesis and repair, mitigating damage while still allowing the antifolate drug to target rapidly dividing cancer cells.
  • Enhancing Chemotherapy Efficacy: When used in combination with certain chemotherapy agents, particularly 5-fluorouracil (5-FU), Leucovorin enhances the cytotoxic effect of the chemotherapy. It does this by stabilizing the binding of 5-FU's active metabolite to thymidylate synthase, an enzyme critical for DNA synthesis. This stabilization prolongs the inhibition of DNA synthesis in cancer cells, thereby increasing the effectiveness of 5-FU in killing these cells.

Medical Uses

Leucovorin has several critical medical applications, primarily in oncology and in managing certain drug toxicities:

  • Methotrexate Rescue

    This is perhaps the most well-known and vital use of Leucovorin. High-dose methotrexate therapy is a common treatment for various cancers, but it can cause severe toxicity to normal cells, especially in the bone marrow and gastrointestinal tract. Methotrexate rescue involves administering Leucovorin at specific times after methotrexate to protect healthy cells from its damaging effects, allowing the body to recover while the methotrexate continues to act on cancer cells.
  • Chemotherapy Adjunct

    Leucovorin is frequently used in combination with 5-fluorouracil (5-FU) to treat various cancers, including colorectal cancer treatment, breast cancer, and gastric cancer. In this context, Leucovorin is not a rescue agent but rather acts as an enhancer, boosting the anti-tumor activity of 5-FU by stabilizing its binding to thymidylate synthase, thereby increasing its effectiveness in killing cancer cells. This is a common strategy in a broader chemotherapy adjunct approach.
  • Folate Deficiency Treatment

    While not its primary use, Leucovorin can be used to treat certain megaloblastic anemias resulting from folate deficiency treatment when oral folic acid supplementation is insufficient or contraindicated. This is particularly relevant in cases where there is malabsorption or an enzyme deficiency that prevents the conversion of folic acid to its active forms.
  • Overdose of Trimethoprim or Pyrimethamine

    Similar to its use with methotrexate, Leucovorin can counteract the antifolate effects of drugs like trimethoprim (found in co-trimoxazole) and pyrimethamine, which are used to treat infections and parasitic diseases, respectively.

Dosage

The dosage of Leucovorin is highly individualized and depends significantly on the specific medical condition being treated, the patient's overall health, and the concomitant use of other medications. It can be administered orally or via injection (intravenous or intramuscular).

  • For Methotrexate Rescue: Dosing is complex and precisely timed, often starting 24 hours after the initiation of high-dose methotrexate. The dose and duration are guided by serum methotrexate levels and the patient's renal function. It typically continues until methotrexate levels fall below a certain threshold.
  • As a Chemotherapy Adjunct with 5-FU: Leucovorin is usually administered before or concurrently with 5-FU. The specific regimen (e.g., bolus vs. continuous infusion) and dose vary widely depending on the cancer type and the overall chemotherapy protocol.
  • For Folate Deficiency: Doses are generally lower and administered daily until the deficiency is resolved.

It is crucial that Leucovorin dosage and administration are strictly supervised by a healthcare professional experienced in its use, especially in oncological settings, due to the precise timing and potential interactions involved.

Side Effects

Leucovorin is generally well-tolerated, especially when used alone for methotrexate rescue or folate deficiency. However, side effects can occur, and their frequency and severity can increase when Leucovorin is used in combination with other potent chemotherapy drugs like 5-fluorouracil.

Common side effects when used alone are rare but may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Rash
  • Allergic reactions (rare, but can be severe)

When used with 5-fluorouracil, Leucovorin can potentiate the side effects of 5-FU, leading to an increased incidence or severity of:

  • Mucositis (inflammation and ulceration of mucous membranes, particularly in the mouth and gut)
  • Diarrhea (can be severe and lead to dehydration)
  • Myelosuppression (bone marrow suppression, leading to decreased white blood cells, red blood cells, and platelets)
  • Hand-foot syndrome (redness, swelling, and pain on the palms of the hands and soles of the feet)

Patients should report any unusual or severe side effects to their doctor immediately.

Drug Interactions

Leucovorin can interact with several medications, altering their efficacy or toxicity. Key interactions include:

  • Fluorouracil (5-FU): As discussed, Leucovorin significantly enhances the cytotoxic and toxic effects of 5-FU. This interaction is therapeutically desired in cancer treatment but necessitates careful monitoring for increased side effects.
  • Methotrexate: Leucovorin directly counteracts the effects of methotrexate, reducing its toxicity to normal cells. This is the basis of methotrexate rescue therapy. However, if administered inappropriately (e.g., too early or in too high a dose relative to methotrexate), it can reduce the anti-cancer efficacy of methotrexate.
  • Anticonvulsants (e.g., Phenytoin, Phenobarbital, Primidone): Leucovorin may decrease the plasma levels of these anticonvulsant drugs, potentially leading to a loss of seizure control. Close monitoring of anticonvulsant levels may be required.
  • Co-trimoxazole (Trimethoprim-Sulfamethoxazole) and Pyrimethamine: Leucovorin can reduce the effectiveness of these antifolate antimicrobial agents by providing the active folate that these drugs are designed to deplete.

Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to prevent potential drug interactions.

FAQ

  • Is Leucovorin the same as folic acid?

    No, they are related but distinct. Folic acid is a precursor that needs enzymatic conversion to become active, while Leucovorin (folinic acid) is a reduced, more active form of folate that bypasses this step, making it immediately available to the body.

  • Why is Leucovorin called a "rescue" drug?

    It's called a "rescue" drug primarily because of its ability to mitigate the severe toxic effects of high-dose methotrexate on healthy cells. By providing active folate, it rescues normal cells from methotrexate's antifolate action.

  • Can Leucovorin cause hair loss?

    Leucovorin itself is generally not associated with hair loss. However, when used as a chemotherapy adjunct with drugs like 5-fluorouracil, which can cause hair thinning or loss, it might be indirectly associated with such side effects as it enhances the overall chemotherapy toxicity.

  • Who should not take Leucovorin?

    Leucovorin should generally not be used in patients with pernicious anemia or other megaloblastic anemias where vitamin B12 deficiency is the cause, as it can mask the symptoms of B12 deficiency while allowing neurological damage to progress. Patients with a known hypersensitivity to Leucovorin or any of its components should also avoid it.

Products containing Leucovorin are available through trusted online pharmacies. You can browse Leucovorin-based medications at ShipperVIP or Medicenter.

Summary

Leucovorin, also known as folinic acid or sodium folinate, is a crucial medication with diverse applications, predominantly in oncology. Its ability to provide active folate directly to the body makes it invaluable for methotrexate rescue, protecting healthy cells from high-dose chemotherapy toxicity. Furthermore, it serves as an effective chemotherapy adjunct, significantly enhancing the anti-tumor activity of 5-fluorouracil in the treatment of various cancers, including colorectal cancer treatment. While generally well-tolerated, especially when used alone, its combination with other potent chemotherapy agents can amplify their side effects. Understanding its precise mechanism, appropriate dosage, and potential interactions is vital for its safe and effective use. Always consult a healthcare professional for guidance on Leucovorin therapy, ensuring optimal outcomes and minimizing risks in specific folate deficiency treatment scenarios or complex cancer regimens.